Uncoupling effects of estrogen receptor α on LKB1/AMPK interaction upon adiponectin exposure in breast cancer.
Mauro L, Naimo GD, Gelsomino L, Malivindi R, Bruno L, Pellegrino M, Tarallo R, Memoli D, Weisz A, Panno ML, Andò S.
Mauro L, et al. Among authors: memoli d.
FASEB J. 2018 Aug;32(8):4343-4355. doi: 10.1096/fj.201701315R. Epub 2018 Mar 7.
FASEB J. 2018.
PMID: 29513571
In other words, in ERalpha-positive breast cancer obese patients, higher adiponectin doses should be administered with respect to ERalpha-negative breast cancer, also opportunely combined with antiestrogen therapy. -Mauro, L., Naimo, G. D., Gelsomino, L., Malivindi, R., Br …
In other words, in ERalpha-positive breast cancer obese patients, higher adiponectin doses should be administered with respect to ERalpha-ne …